A dual GLP-1 and gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice
The receptor profiles are different (dual versus triple agonist), the potency per milligram is different, and the side effect profiles are different
It handles consultations, messaging, and prescription management without the engagement features that Noom provides
For GLP-1 users who want microbiome support without the gastrointestinal drama, acacia fiber is worth serious consideration
According to the recently completed ELIXA and LEADER trials, an increase in HR, regardless of its magnitude, does not appear to increase the cardiovascular risk of individuals with T2DM and with (or at high risk of) cardiovascular disease
In SURMOUNT-4, adults who had lost an average of 20.9% on Mounjaro then switched to placebo regained 14% of their starting weight over the following year, retaining only about a third of the weight loss theyd initially achieved